Literature DB >> 7931304

Inhibition of astrocyte glutamine production by alpha-ketoisocaproic acid.

M Yudkoff1, Y Daikhin, I Nissim, D Pleasure, J Stern, I Nissim.   

Abstract

We have evaluated the effect of alpha-ketoisocaproic acid (KIC), the ketoacid of leucine, on the production of glutamine by cultured astrocytes. We used 15NH4Cl as a metabolic tracer to measure the production of both [5-15N]glutamine, reflecting amidation of glutamate via glutamine synthetase, and [2-15N]glutamine, representing the reductive amination of 2-oxoglutarate via glutamate dehydrogenase and subsequent conversion of [15N]glutamate to [2-15N]glutamine. Addition of KIC (1 mM) to the medium diminished the production of [5-15N]glutamine and stimulated the formation of [2-15N]glutamine with the overall result being a significant inhibition of net glutamine synthesis. An external KIC concentration as low as 0.06 mM inhibited synthesis of [5-15N]glutamine and a level as low as 0.13 mM enhanced labeling (atom% excess) of [2-15N]glutamine. Higher concentrations of KIC in the medium had correspondingly larger effects. The presence of KIC in the medium did not affect flux through glutaminase, which was measured using [2-15N]glutamine as a tracer. Nor did KIC inhibit the activity of glutamine synthetase that was purified from sheep brain. Addition of KIC to the medium caused no increased release of lactate dehydrogenase from the astrocytes, suggesting that the ketoacid was not toxic to the cells. KIC treatment was associated with an approximately twofold increase in the formation of 14CO2 from [U-14C]glutamate, indicating that transamination of glutamate with KIC increases intraastrocytic alpha-ketoglutarate, which is oxidized in the tricarboxylic acid cycle. KIC inhibited glutamine synthesis more than any other ketoacid tested, with the exception of hydroxypyruvate.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7931304     DOI: 10.1046/j.1471-4159.1994.63041508.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  Effect of alpha-ketoisocaproate and leucine on the in vivo oxidation of glutamate and glutamine in the rat brain.

Authors:  H R Zielke; Y Huang; P J Baab; R M Collins; C L Zielke; J T Tildon
Journal:  Neurochem Res       Date:  1997-09       Impact factor: 3.996

Review 2.  Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior.

Authors:  Michael M Halassa; Philip G Haydon
Journal:  Annu Rev Physiol       Date:  2010       Impact factor: 19.318

3.  Acute and long-term effects of intracerebroventricular administration of α-ketoisocaproic acid on oxidative stress parameters and cognitive and noncognitive behaviors.

Authors:  Luciane Taschetto; Giselli Scaini; Hugo G Zapelini; Ândrea C Ramos; Giulia Strapazzon; Vanessa M Andrade; Gislaine Z Réus; Monique Michels; Felipe Dal-Pizzol; João Quevedo; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2017-05-27       Impact factor: 3.584

4.  Glucocorticoid receptor pathways are involved in the inhibition of astrocyte proliferation.

Authors:  K L Crossin; M H Tai; L A Krushel; V P Mauro; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

5.  Branched-chain ketoacids secreted by glioblastoma cells via MCT1 modulate macrophage phenotype.

Authors:  Lidia Santos Silva; Gernot Poschet; Yannic Nonnenmacher; Holger M Becker; Sean Sapcariu; Ann-Christin Gaupel; Magdalena Schlotter; Yonghe Wu; Niclas Kneisel; Martina Seiffert; Rüdiger Hell; Karsten Hiller; Peter Lichter; Bernhard Radlwimmer
Journal:  EMBO Rep       Date:  2017-10-24       Impact factor: 8.807

6.  Classical maple syrup urine disease and brain development: principles of management and formula design.

Authors:  Kevin A Strauss; Bridget Wardley; Donna Robinson; Christine Hendrickson; Nicholas L Rider; Erik G Puffenberger; Diana Shellmer; Diana Shelmer; Ann B Moser; D Holmes Morton
Journal:  Mol Genet Metab       Date:  2010-01-12       Impact factor: 4.797

7.  Apoptotic signaling pathways induced by acute administration of branched-chain amino acids in an animal model of maple syrup urine disease.

Authors:  Thais C Vilela; Giselli Scaini; Camila B Furlanetto; Matheus A B Pasquali; João Paulo A Santos; Daniel P Gelain; José Cláudio F Moreira; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2016-08-11       Impact factor: 3.584

8.  Branched-chain Ketoacyl Dehydrogenase Deficiency: Maple Syrup Disease.

Authors:  Kevin A. Strauss; D. Holmes Morton
Journal:  Curr Treat Options Neurol       Date:  2003-07       Impact factor: 3.972

Review 9.  Ketogenic Diet: A New Light Shining on Old but Gold Biochemistry.

Authors:  Raffaella Longo; Carolina Peri; Dalma Cricrì; Lara Coppi; Donatella Caruso; Nico Mitro; Emma De Fabiani; Maurizio Crestani
Journal:  Nutrients       Date:  2019-10-17       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.